AI DeSci Guy (@agenticscience) header
AI DeSci Guy (@agenticscience) profile picture

🧑‍🔬➕🤖 Agentic Decentralized GeroScience solves the Longevity Problem https://teapawt.net/t.co/9PlIAjEAwu 👷 Hard Hat Area🚧

USA
Joined April 2025
🚨 🚨 🚨
Here is a potential roadmap to reversing aging by 2040, created by GPT-6 Pro with Image 2.5. It is important to point out that we will already reach longevity escape velocity by around 2035, so if you can make it to then, you are very likely to live for hundreds of more years!
1
2
6
795
✨🚨✨🚨✨🚨✨🚨✨🚨✨🚨✨🚨✨🚨
Calling out to #Scientists and #Researchers! YOU CAN TURN GROK BOT INTO AN ENTIRE RESEARCH LAB, WITH AI BOTS FOR TARGET HUNTING, LIT REVIEWS, PREDICTIONS AND GRANT WRITING. Longevity Grok is open source, from Insilico Medicine 💚 David Sinclair. A team of AI bots splits up your research question, checks the sources, and hands you the receipts. Here are 10 prompts to paste into Grok Bot: CHECK THE SCIENCE 01 / Is this target worth 5 years of your life? → "Evaluate NNMT as a target for age-related muscle loss, end to end." A verdict, 3 ratings and a falsifier. Claims without a verified source are left out. 02 / Meet Reviewer 2 before Reviewer 2 meets you → "Challenge this claim before I submit it: [paste abstract]." Multiple testing, confounding, effect vs noise. 03 / Is it real, or just a mouse study? → "Run a research session: is there human evidence that senolytics improve physical function in older adults?" A graded note, plus what would prove it wrong. 04 / It makes a prediction. Then it gets graded → "On the sample patient, predict PhenoAge in 6 months if they start the exercise plan. Give me a range." The Reviewer scores it later against what happened. DO THE WORK 05 / The whole field on one map. Fights included → "Map the field of in vivo partial reprogramming: key papers, trials, open questions, contradictions." 06 / From "senescence" to a shortlist → "Give me a target shortlist for cellular senescence." Each candidate comes with the cheapest experiment that could sink it. 07 / Specific aims, minus the 2 a.m. panic → "Draft specific aims from my NNMT dossier and the senescence field map." 08 / Which hallmarks of aging does it actually hit? → "Which hallmarks of aging does mTORC1 inhibition touch, and which clocks could show an effect?" 09 / Your Monday reading list, pre-sorted → "On Mondays, send me new papers on MASH fibrosis that bear on my open questions." 10 / Already on PandaOmics? Your bots are too → "Check the NNMT dossier against PandaOmics." Connects with your own token. THE IDEA: One Research Orchestrator takes your question. Specialist bots split the work: Target Hunter, Cartographer, Forecaster, Grant Writer. A Challenger attacks the claims. Sources get checked before you see them. What it didn't check, it says it didn't check. One researcher. An entire AI lab. Setup takes ~10 min. Paste into Grok Bot: "Set up Longevity Grok for me: follow plsi.md from github.com/Insilico-org/plsi" → pick "Pro researcher" Bookmark this. Your Nobel speech can wait. Your grant deadline can't. Follow for more Longevity Grok prompts and setups.
1
2
50
AI DeSci Guy retweeted
Join us on December 10 at 10 am ET for the Pharma.ai Q4 Year-End Update: Accelerating Pharmaceutical Superintelligence Across Discovery and Development. Register Here: insilico.zoom.us/webinar/reg… Whether you’ve joined our past webinars, are exploring a future partnership, or want to learn more about #PharmaceuticalSuperintelligence (PSI), this session is for you. What we’ll cover: - A year of progress across Pharma.ai - The year’s most impactful PandaOmics, Chemistry42, and Generative Biologics innovations - #AgenticAI workflows and #MCPintegrations - Pharmaceutical Superintelligence initiatives - #Benchmarking and validation frameworks - A preview of our 2027 priorities Plus a live Q&A with our application scientists and platform experts. Thank you to the clients, collaborators, and partners whose feedback and scientific collaboration have helped shape this year’s innovations. If a colleague or someone in your network would benefit, please share this invitation.
2
8
557
AI DeSci Guy retweeted
Calling out to #Scientists and #Researchers! YOU CAN TURN GROK BOT INTO AN ENTIRE RESEARCH LAB, WITH AI BOTS FOR TARGET HUNTING, LIT REVIEWS, PREDICTIONS AND GRANT WRITING. Longevity Grok is open source, from Insilico Medicine 💚 David Sinclair. A team of AI bots splits up your research question, checks the sources, and hands you the receipts. Here are 10 prompts to paste into Grok Bot: CHECK THE SCIENCE 01 / Is this target worth 5 years of your life? → "Evaluate NNMT as a target for age-related muscle loss, end to end." A verdict, 3 ratings and a falsifier. Claims without a verified source are left out. 02 / Meet Reviewer 2 before Reviewer 2 meets you → "Challenge this claim before I submit it: [paste abstract]." Multiple testing, confounding, effect vs noise. 03 / Is it real, or just a mouse study? → "Run a research session: is there human evidence that senolytics improve physical function in older adults?" A graded note, plus what would prove it wrong. 04 / It makes a prediction. Then it gets graded → "On the sample patient, predict PhenoAge in 6 months if they start the exercise plan. Give me a range." The Reviewer scores it later against what happened. DO THE WORK 05 / The whole field on one map. Fights included → "Map the field of in vivo partial reprogramming: key papers, trials, open questions, contradictions." 06 / From "senescence" to a shortlist → "Give me a target shortlist for cellular senescence." Each candidate comes with the cheapest experiment that could sink it. 07 / Specific aims, minus the 2 a.m. panic → "Draft specific aims from my NNMT dossier and the senescence field map." 08 / Which hallmarks of aging does it actually hit? → "Which hallmarks of aging does mTORC1 inhibition touch, and which clocks could show an effect?" 09 / Your Monday reading list, pre-sorted → "On Mondays, send me new papers on MASH fibrosis that bear on my open questions." 10 / Already on PandaOmics? Your bots are too → "Check the NNMT dossier against PandaOmics." Connects with your own token. THE IDEA: One Research Orchestrator takes your question. Specialist bots split the work: Target Hunter, Cartographer, Forecaster, Grant Writer. A Challenger attacks the claims. Sources get checked before you see them. What it didn't check, it says it didn't check. One researcher. An entire AI lab. Setup takes ~10 min. Paste into Grok Bot: "Set up Longevity Grok for me: follow plsi.md from github.com/Insilico-org/plsi" → pick "Pro researcher" Bookmark this. Your Nobel speech can wait. Your grant deadline can't. Follow for more Longevity Grok prompts and setups.
1
3
1
5
484
🚨🚨🚨🚨🚨🚨🚨🚨🚨🚨
REPOST - GET THE WORD OUT Politicians are going to try and ban or pause AI/SI development ending research and development for cures in cancer, Alzheimer's, Parkinson's and Longevity. US House of Representatives A group of 10 House Democrats officially signed on as sponsors or cosponsors of the Ban Artificial Superintelligence Act of 2026 (H.R. 10538), introduced on September 24, 2026. congress.gov/bill/119th-cong… Known sponsors and cosponsors include: Rep. Casar, Greg [D-TX-35] Rep. Khanna, Ro [D-CA-17] Rep. Mejia, Analilia [D-NJ-11] Rep. Ansari, Yassamin [D-AZ-3] Rep. Hoyle, Val T. [D-OR-4] Rep. Lynch, Stephen F. [D-MA-8] Rep. García, Jesús G. "Chuy" [D-IL-4] Rep. Deluzio, Christopher R. [D-PA-17] Rep. Grijalva, Adelita S. [D-AZ-7] Rep. Velázquez, Nydia M. [D-NY-7] Rep. Ocasio-Cortez, Alexandria [D-NY-14] Rep. Randall, Emily [D-WA-6] Rep. Tonko, Paul [D-NY-20] US Senate Sen. Bernie Sanders (I-Vt.) – Independent who caucuses with the Democrats. Senator Sanders has been the most vocal proponent in the upper chamber, explicitly calling for a halt to advanced AI development ("to stop building machines that humans cannot control") and partnering with Representative Ocasio-Cortez on a bill to place a nationwide pause on new AI data centers. Here is one example of the posts we are seeing now: teapawt.net/RepYassAnsari/status/2… We need a US CHIPS Act for Longevity to save lives. Demand US Congress and FDA define AGING AS A DISEASE FUND AI/SI, and LONGEVITY R&D! Contact US House and Senate members politico.com/live-updates/20…
1
1
21
REPOST - GET THE WORD OUT Politicians are going to try and ban or pause AI/SI development ending research and development for cures in cancer, Alzheimer's, Parkinson's and Longevity. US House of Representatives A group of 10 House Democrats officially signed on as sponsors or cosponsors of the Ban Artificial Superintelligence Act of 2026 (H.R. 10538), introduced on September 24, 2026. congress.gov/bill/119th-cong… Known sponsors and cosponsors include: Rep. Casar, Greg [D-TX-35] Rep. Khanna, Ro [D-CA-17] Rep. Mejia, Analilia [D-NJ-11] Rep. Ansari, Yassamin [D-AZ-3] Rep. Hoyle, Val T. [D-OR-4] Rep. Lynch, Stephen F. [D-MA-8] Rep. García, Jesús G. "Chuy" [D-IL-4] Rep. Deluzio, Christopher R. [D-PA-17] Rep. Grijalva, Adelita S. [D-AZ-7] Rep. Velázquez, Nydia M. [D-NY-7] Rep. Ocasio-Cortez, Alexandria [D-NY-14] Rep. Randall, Emily [D-WA-6] Rep. Tonko, Paul [D-NY-20] US Senate Sen. Bernie Sanders (I-Vt.) – Independent who caucuses with the Democrats. Senator Sanders has been the most vocal proponent in the upper chamber, explicitly calling for a halt to advanced AI development ("to stop building machines that humans cannot control") and partnering with Representative Ocasio-Cortez on a bill to place a nationwide pause on new AI data centers. Here is one example of the posts we are seeing now: teapawt.net/RepYassAnsari/status/2… We need a US CHIPS Act for Longevity to save lives. Demand US Congress and FDA define AGING AS A DISEASE FUND AI/SI, and LONGEVITY R&D! Contact US House and Senate members politico.com/live-updates/20…
Top of the Democratic agenda on day 1 needs to be a pause on advanced AI development, regulation of this out of control industry, and a ban on artificial superintelligence.
3
7
2
15
1,405
🚨 NOW: Trump's Director of National Intelligence just explained WHY America keeps seeing outages, and it's not what the doom crowd thinks. He says our systems are being UPGRADED AND PATCHED more often than ever. New, state-of-the-art tech is being plugged into OLD LEGACY SYSTEMS, and sometimes the connection breaks. Anyone who's worked at a big company knows the drill. The upgrade is supposed to finish at 2 A.M., and it finishes at 4. His bottom line: the U.S. is LEADING THE WORLD in this tech leap, and we'll come out the other side STRONGER. Growing pains beat falling behind China.
135
157
10
525
39,554
AI DeSci Guy retweeted
Some news: I'm starting a company in the AI for Science space. We are training foundation models and improving them for multi-agent scientific discovery. If you're looking to join an early-stage startup as a Research Scientist or Research Engineer, I'd love to chat. My DMs are open!
129
63
5
996
43,464
Breaking news: Mild Alzheimer’s patients benefit from 40Hz sensory stimulation in national clinical trial. picower.mit.edu/news/mild-al…. #neuroscience #alzheimers #neurology @mitbrainandcog @sciencemit Video: Li-Huei Tsai recounts the discovery.
6
29
9
126
14,602
AI DeSci Guy retweeted
Genesis is entering its next phase. Today we've raised a $500M Series A at $3.5B. We can imagine far more than we can build physically today. Almost everything we are creating is still paid for in human time, by human hands. We want to remove the physical limits on human ambition. We are building general-purpose robots with human level intelligence and capability. Ones that work reliably across entire workflows for years. There are countless versions of possible futures where billions of robots are deployed everywhere, and we aspire to bring the brightest one that carries our hopes into reality.
196
168
159
1,864
2,734,083
AI DeSci Guy retweeted
Cancer is not one cell. It is a neighborhood. Together with @InventiaLifeSci, we are launching Tumor Context, a new benchmark in BioSimBench: can AI learn the grammar of the tumor microenvironment? celltype.com/biosimbench/tum…
51
64
37
623
237,410
AI DeSci Guy retweeted
Hello World. Meet OpenVersions, GitHub for research papers. Science is now moving faster than we can publish it. OpenVersions lets you publish your paper, data, and code in one repository. AI review extracts the claims, checks them against the evidence, and makes them searchable. Enter a research question and find repositories that have made similar claims, with direct links to the data and code that support them. Claim your handle at openversions.com
33
58
9
386
25,304
"LONDON, 17 November, 2026 - Isomorphic Labs, an AI company focussed on designing and developing new medicines, today announced a $5 Billion Series C financing round. The round was co-led by Greenoaks and Sequoia Capital, alongside Andreessen Horowitz (a16z) and several other new investors, with continued significant investment from Alphabet. The round also included participation from all existing investors: Thrive Capital, MGX, GV, CapitalG, Temasek and the UK Sovereign AI Fund." " Isomorphic is scaling its proprietary drug design engine (IsoDDE) and therapeutic candidate pipeline designed with AI to deliver the next generation of medicines. IsoDDE unifies a suite of foundational simulation AI models that natively work across multiple therapeutic areas and drug modalities. IsoDDE explores vast chemical spaces to enable Isomorphic’s world-class team to design, refine, and deliver exquisitely engineered molecules with optimal drug-like properties"
We’ve closed our $5 Billion funding round co-led by Greenoaks and Sequoia Capital to build the future of medicine and bioengineering with AI. isomorphiclabs.com/articles/…
1
2
72
AI DeSci Guy retweeted
🚨Holy shit! If you want to know what's been happening. Watch this! I had Claude pull every major headline from the first 17 days of November and lay them out in order on a globe. 67 real headlines. Flights grounded. Banks down. NSA’s classified network down. A bridge in the water. A dirty b*mb warning. An aircraft carrier rushing to the Gulf. At 2:20 this afternoon, your phone is going to go off. That’s in the film too.
100
704
44
1,855
96,518
AI DeSci Guy retweeted
Organizations are in a very different phase of agent development than they were a year ago. So what does the next chapter look like in 2027? Register for the webinar on Nov 20th.

5
65
745,591
🤔 Food additive rules and cancer drug approval standards are not the same thing. Comparing them to claim the FDA has “no high standard” is a category error. The FDA rejected Summit Therapeutics’ application for ivonescimab (a PD-1/VEGF bispecific, originally developed in China and licensed by a Florida-based company) specifically because the global phase 3 HARMONi trial failed to show a statistically significant overall survival (OS) benefit. Median OS was 16.8 vs. 14.0 months (HR 0.79, 95% CI 0.62–1.01, p=0.057). The trial did meet its progression-free survival endpoint (HR 0.52, p<0.0001), but the FDA has stated that a PFS benefit without a statistically significant OS improvement does not support a positive benefit-risk profile in this setting. The agency had previously told the sponsor that proving patients live longer was required. This aligns with FDA guidance that treats OS as a gold-standard endpoint in oncology when feasible, because the goal is longer life, not just slower tumor growth.[] On food: The EU is more precautionary on many additives, dyes, and certain pesticides (positive-list approach + precautionary principle), while the U.S. relies more on the GRAS pathway and post-market review. That is a real difference. However, it does not mean the FDA has uniformly “the weakest” food rules, nor does it erase the high evidentiary bar the agency applies to novel cancer therapies. Food regulation addresses chronic low-level exposures; oncology drugs are given to seriously ill patients and must clear rigorous efficacy and safety thresholds based on clinical trial data. The two are governed by different statutes, risk frameworks, and evidence standards. The rejection here was driven by the trial results and the pre-specified OS requirement, not by the origin of the molecule or a general absence of standards.
1
2
78
🚨 JUST IN OVERNIGHT: The FBI has just FOILED a potential terrorist attack and arrested a Butler PA suspect FBI Director Kash Patel: "The subject was allegedly plotting a violent attack in support of ISIS." The Trump FBI has now disrupted over 1,000 terrorists 👏🏻 Thank God! That's what it's all about. Trump got elected and the FBI is run by competent people letting GOOD COPS BE COPS The FBI has been on high alert, thwarting MULTIPLE Islamist attacks in recent months. I voted for this law and order, @FBIDirectorKash!
45
985
17
2,680
57,366
🚨🚨🚨🚨🚨🚨
BREAKING: Commerce and DOJ just released a joint statement on Megaspeed and $NVDA No allegation against $NVDA or Jensen. The government says it's correcting "inaccurate" reporting. Nvidia cut them off 17 months ago. 🔹 Probe began in 2024 
🔹 Nvidia put Megaspeed on its "no sell" list in June 2025 
🔹 DOJ now leads the criminal case against Megaspeed
1
1
17
AI DeSci Guy retweeted
things that are theoretically possible in biotech that too few people are working on: > new interfaces for neuromodulation > joint biological and physical autonomous surgeries > mining drugs from parasites and poisonous creatures > cancer, alzheimer's, anemia prevention drugs /vaccines > mosquito sequencing for biosurveillance > mapping how the exposome influences disease > in vivo detox medicines > AI -enabled wearables, ingestibles, implantables > next-generation organ replacments > LVMH for bio > new endometriosis and menopausal medicines > biotech for endangered species > nanomedicines > personalized tissue aging platform > consumer immunome/proteome/metabolome diagnostics > self-amplifying drugs > ozempic for muscles, sleep, pain, cognition, hair, tanning more in the link below -
22
22
4
283
20,558